Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial
Kudo, Masatoshi, Ueshima, Kazuomi, Chiba, Yasutaka, Ogasawara, Sadahisa, Obi, Shuntaro, Izumi, Namiki, Aikata, Hiroshi, Nagano, Hiroaki, Hatano, Etsuro, Sasaki, Yutaka, Hino, Keisuke, Kumada, Takashi,Volume:
8
Year:
2019
Journal:
Liver Cancer
DOI:
10.1159/000503032
File:
PDF, 972 KB
2019